DOCSLIB.ORG

Full Automation List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Full Automation List Automation List from 1st March 2012 Abidec Drops Packsize 25 Adalimumab Inj 40 Mg/0.8ml Solution For Injection In Prefilled Abilify Tabs 10 Mg Packsize 28 Pen Packsize 2 Abstral Tabs 100 Micrograms Packsize 10 Adalimumab Inj 40 Mg/0.8ml Solution For Injection In Prefilled Abstral Tabs 100 Micrograms Packsize 30 Syringe Packsize 2 Abstral Tabs 200 Micrograms Packsize 10 Adapalene Cream .1 % Packsize 45 Abstral Tabs 200 Micrograms Packsize 30 Adapalene Gel .1 % Packsize 45 Abstral Tabs 300 Micrograms Packsize 10 Adartrel Tabs 2 Mg Packsize 28 Abstral Tabs 300 Micrograms Packsize 30 Adartrel Tabs 250 Micrograms Packsize 12 Abstral Tabs 400 Micrograms Packsize 10 Adartrel Tabs 500 Micrograms Packsize 28 Abstral Tabs 400 Micrograms Packsize 30 Adcal 1.5 G Sf Contains Calcium 600mg Chewable Tabs Abstral Tabs 600 Micrograms Packsize 30 Packsize 100 Acamprosate Calcium 333 Mg Ec Tabs Packsize 168 Adcal D3 Chewable Tabs Packsize 112 Acarbose Tabs 100 Mg Packsize 90 Adcal D3 Chewable Tabs Packsize 112 Acarbose Tabs 50 Mg Packsize 90 Adcal D3 Chewable Tabs Packsize 56 Accolate Tabs 20 Mg Packsize 56 Adcal D3 Chewable Tabs Packsize 56 Accupro Tabs 10 Mg Packsize 28 Adcal D3 Dissolve Effervescent Tabs Packsize 56 Accupro Tabs 20 Mg Packsize 28 Adcal D3 Tabs Packsize 112 Accupro Tabs 40 Mg Packsize 28 Adefovir Dipivoxil Tabs 10 Mg Packsize 30 Accupro Tabs 5 Mg Packsize 28 Adenuric Tabs 80 Mg Packsize 28 Accuretic Tabs Packsize 28 Adipine 10 Mr 10 Mg Tabs Packsize 56 Acebutolol Caps 100 Mg Packsize 84 Adipine 20 Mr 20 Mg Tabs Packsize 56 Acebutolol Caps 200 Mg Packsize 56 Adipine 30 Xl Tabs 30 Mg Packsize 28 Acebutolol Tabs 400 Mg Packsize 28 Adipine 60 Xl Tabs 60 Mg Packsize 28 Aceclofenac Tabs 100 Mg Packsize 60 Adizem Sr 120 Mg Caps Packsize 56 Aceclofenac Tabs 100 Mg Packsize 60 Adizem Sr 180 Mg Caps Packsize 56 Aceclofenac Tabs 100 Mg Packsize 60 Adizem Sr 90 Mg Caps Packsize 56 Aceclofenac Tabs 100 Mg Packsize 60 Adizem Sr Tabs 120 Mg Packsize 56 Acemetacin Caps 60 Mg Packsize 90 Adizem Xl 120 Mg Caps Packsize 28 Acenocoumarol Tabs 1 Mg Packsize 100 Adizem Xl 180 Mg Caps Packsize 28 Acetazolamide Mr Caps 250 Mg Packsize 30 Adizem Xl 200 Mg Caps Packsize 28 Acetazolamide Tabs 250 Mg Packsize 112 Adizem Xl 240 Mg Caps Packsize 28 Acetazolamide Tabs 250 Mg Packsize 112 Adizem Xl 300 Mg Caps Packsize 28 Acetic Acid 2 % Spray Ear Pump 5ml Packsize 1 Adoport Caps 1 Mg Packsize 100 Acetylcysteine 200 Mg/Ml Inj Amp 10ml Packsize 10 Adoport Caps 1 Mg Packsize 50 Aciclovir 200 Mg Tabs Packsize 25 Adoport Caps 500 Micrograms Packsize 50 Aciclovir 200 Mg Dispersible Tabs Packsize 25 Advagraf Caps 1 Mg Packsize 100 Aciclovir 200 Mg/5ml Susp Sf Packsize 125 Advagraf Caps 1 Mg Packsize 50 Aciclovir 200 Mg/5ml Susp Sf Packsize 125 Advagraf Caps 3 Mg Packsize 50 Aciclovir 3 % Eye Oint Packsize 4.5 Advagraf Caps 5 Mg Packsize 50 Aciclovir 400 Mg Tabs Packsize 56 Advagraf Caps 500 Micrograms Packsize 50 Aciclovir 400 Mg Dispersible Tabs Packsize 56 Agnus Castus Tabs 30 C Packsize 50 Aciclovir 400 Mg/5ml Susp Sf Packsize 100 Agomelatine Tabs 25 Mg Packsize 28 Aciclovir 5 % Cream Packsize 10 Airomir 100 Mcg/Dose 200 Dose Cfc Free Inhal Packsize 1 Aciclovir 5 % Cream Packsize 2 Airomir Autohaler 100 Mcg/Dose 200 Dose Cfc Free Inhal Aciclovir 5 % Cream Cold Sore Pump Packsize 2 Packsize 1 Aciclovir 800 Mg Tabs Packsize 35 Aknemin Caps 100 Mg Packsize 28 Aciclovir 800 Mg Dispersible Tabs Packsize 35 Aknemin Caps 50 Mg Packsize 56 Aciclovir Susp 200 Mg/5ml Sf Packsize 125 Aknemycin Plus Sol Packsize 25 Aciclovir Susp 400 Mg/5ml Sf Packsize 100 Alateris Tabs 625 Mg Packsize 60 Acipimox Caps 250 Mg Packsize 90 Alclometasone Dipropionate Cream .05 % Packsize 50 Acitretin Caps 10 Mg Packsize 60 Alclometasone Dipropionate Oint .05 % Packsize 50 Acitretin Caps 25 Mg Packsize 60 Alcohol Packsize 2000 Acnamino Mr Caps 100 Mg Packsize 56 Aldactide 25 Tabs Packsize 100 Aconite Napellus Tabs 30 C Packsize 125 Aldactide 50 Tabs Packsize 100 Aconite Tabs 30 C Packsize 84 Aldactide 50 Tabs Packsize 28 Aconite Tabs 6 C Packsize 125 Aldactone Tabs 100 Mg Packsize 28 Acriflex Cream .25 % Packsize 30 Aldactone Tabs 25 Mg Packsize 100 Acrivastine 8 Mg Caps Packsize 24 Aldactone Tabs 50 Mg Packsize 100 Acrivastine Caps 8 Mg Packsize 12 Aldara Cream Sach 5 % Packsize 12 Actikerall Sol Packsize 25 Aldomet Tabs 250 Mg Packsize 60 Actonel 35 Mg Once A Week Tabs Packsize 4 Aldomet Tabs 500 Mg Packsize 30 Actonel Tabs 30 Mg Packsize 28 Alendronic Acid 10 Mg Tabs Packsize 28 Actonel Tabs 5 Mg Packsize 28 Alendronic Acid 70 Mg Once Weekly Tabs Packsize 4 Actos 30mg Tabs Packsize 28 Alendronic Acid Soln 70 Mg/100ml Packsize 4 Actos 45 Mg Tabs Packsize 28 Alfacalcidol 1 Micrograms Caps Packsize 30 Acular Drops .5 % Packsize 5 Alfacalcidol 250 Nanograms Caps Packsize 30 Adalat 10 Retard 10 Mg Tabs Packsize 56 Alfacalcidol 500 Nanograms Caps Packsize 30 Adalat 5 Caps 5 Mg Packsize 90 Alfacalcidol Drops 2 Mcg/Ml Packsize 10 Adalat Caps 10 Mg Packsize 90 Alfacalcidol Inj 2 Mcg/Ml Amp Packsize 10 Adalat La 20 Mg Tabs Packsize 28 Alfacalcidol Inj 2 Mcg/Ml Amp Packsize 10 Adalat La 30 Mg Tabs Packsize 28 Alfentanil 5 Mg/Ml Inj Intensive Care Amp 1ml Packsize 10 Adalat La 60 Mg Tabs Packsize 28 Alfentanil 5 Mg/Ml Inj Intensive Care Amp 1ml Packsize 10 Adalat Retard 20 Mg Tabs Packsize 56 Alfentanil 500 Mcg/Ml Inj Amp 2ml Packsize 10 Alfentanil 500 Mcg/Ml Inj Amp 2ml Packsize 10 Aluminium Oxide 38.09 % Paste No 1 Packsize 75 Alfentanil Inj 500 Mcg/Ml Amp Packsize 5 Alventa Xl Caps 150 Mg Packsize 28 Alfuzosin Hydrochloride 2.5 Mg Tabs Packsize 28 Alventa Xl Caps 75 Mg Packsize 28 Alfuzosin Hydrochloride Mr 10 Mg Tabs Packsize 30 Alverine Citrate 120 Mg Caps Packsize 60 Algesal 10 % Cream Packsize 50 Alverine Citrate 60 Mg Caps Packsize 100 Algesal Cream 10 % Packsize 100 Alverine Citrate Caps 120 Mg Packsize 60 Alimemazine Tartrate 10 Mg Tabs Packsize 28 Alverine Citrate Caps 60 Mg Packsize 100 Alimemazine Tartrate 7.5 Mg/5ml Syrup Packsize 100 Alvesco Inhal 160 Mcg/Dose Packsize 1 Alimemazine Tartrate Syrup 30 Mg/5ml Packsize 100 Alvesco Inhal 160 Mcg/Dose Packsize 1 Aliskiren Tabs 150 Mg Packsize 28 Alvesco Inhal 80 Mcg/Dose Packsize 1 Aliskiren Tabs 300 Mg Packsize 28 Amantadine Hydrochloride Syrup 50 Mg/5ml Packsize 150 Alitretinoin Caps 10 Mg Packsize 30 Amaryl Tabs 1 Mg Packsize 30 Alitretinoin Caps 30 Mg Packsize 30 Amaryl Tabs 2 Mg Packsize 30 Allegron 10 Mg Tabs Packsize 100 Amaryl Tabs 3 Mg Packsize 30 Allegron 25 Mg Tabs Packsize 100 Amaryl Tabs 4 Mg Packsize 30 Alli Caps 60 Mg Packsize 84 Amfebutamone Hydrochloride Mr Tabs 150 Mg Packsize 60 Allium Cepa Tabs 6 C Packsize 125 Amias 16mg Tabs Packsize 28 Allopurinol 100 Mg Tabs Packsize 28 Amias 2 Mg Tabs Packsize 7 Allopurinol 300 Mg Tabs Packsize 28 Amias 4mg Tabs Packsize 28 Almogran Tabs 12.5 Mg Packsize 3 Amias 8 Mg Tabs Packsize 28 Almogran Tabs 12.5 Mg Packsize 6 Amiloride 5 Mg Tabs Packsize 28 Almogran Tabs 12.5 Mg Packsize 9 Amiloride 5 Mg Tabs Packsize 28 Almond Oil Packsize 50 Amiloride Hydrochloride Soln 5 Mg/5ml Sf Packsize 150 Almond Oil Packsize 500 Amiloride Hydrochloride Soln 5 Mg/5ml Sf Packsize 150 Almotriptan 12.5 Mg Tabs Packsize 6 Amiloride Soln 5 Mg/5ml Packsize 150 Almotriptan 12.5 Mg Tabs Packsize 9 Aminophylline Mr Tabs 350 Mg Packsize 56 Almotriptan Tabs 12.5 Mg Packsize 3 Amiodarone Hydrochloride 100 Mg Tabs Packsize 28 Alomide .1 % Drops Eye Packsize 10 Amiodarone Hydrochloride 200 Mg Tabs Packsize 28 Alomide Drops .1 % Packsize 5 Amisulpride 100 Mg Tabs Packsize 60 Alpha Tocopheryl Acetate Susp 500 Mg/5ml Packsize 100 Amisulpride 200 Mg Tabs Packsize 60 Alphaderm Cream Packsize 100 Amisulpride 400 Mg Tabs Packsize 60 Alphaderm Cream Packsize 30 Amisulpride 50 Mg Tabs Packsize 60 Alphagan 0.2 % Ophthalmic Sol Packsize 5 Amisulpride Soln 100 Mg/Ml Packsize 60 Alphosyl 2 In 1 Shampoo Packsize 125 Amitriptyline Hydrochloride 10 Mg Tabs Packsize 28 Alphosyl 2 In 1 Shampoo Packsize 250 Amitriptyline Hydrochloride 25 Mg Tabs Packsize 28 Alphosyl Hc Cream Packsize 100 Amitriptyline Hydrochloride 50 Mg Tabs Packsize 28 Alprostadil 1000 Micrograms Sls Urethral Stick Packsize 1 Amitriptyline Soln 25 Mg/5ml Packsize 150 Alprostadil 250 Micrograms Sls Urethral Stick Packsize 1 Amitriptyline Soln 25 Mg/5ml Packsize 150 Alprostadil 500 Micrograms Sls Urethral Stick Packsize 1 Amitriptyline Soln 25 Mg/5ml Packsize 150 Alprostadil 10 Micrograms Inj Sls Packsize 2 Amitriptyline Soln 25 Mg/5ml Sf Oral Packsize 150 Alprostadil 10 Micrograms Inj Sls Dual Chamber Packsize 2 Amitriptyline Soln 50 Mg/5ml Packsize 150 Alprostadil 10 Micrograms Inj Sls Vial Packsize 1 Amitriptyline Soln 50 Mg/5ml Packsize 150 Alprostadil 10 Micrograms Inj Sls Vial Packsize 1 Amitriptyline Soln 50 Mg/5ml Packsize 150 Alprostadil 1000 Micrograms Sls Urethral Stick Packsize 1 Amitriptyline Soln 50 Mg/5ml Sf Oral Packsize 150 Alprostadil 1000 Micrograms Sls Urethral Stick Packsize 6 Amlodipine 10 Mg Tabs Packsize 28 Alprostadil 1000 Micrograms Sls Urethral Stick Packsize 6 Amlodipine 5 Mg Tabs Packsize 28 Alprostadil 20 Micrograms Inj Sls Packsize 2 Amlostin Tabs 10 Mg Packsize 28 Alprostadil 20 Micrograms Inj Sls Dual Chamber Packsize 2 Amlostin Tabs 5 Mg Packsize 28 Alprostadil 20 Micrograms Inj Sls Vial Packsize 1 Ammonium Bicarbonate With Ipecacuanha Mixt Sf Packsize Alprostadil 20 Micrograms Inj Sls Vial Packsize 1 200 Alprostadil 250 Micrograms Sls Urethral Stick Packsize 1 Amorolfine 5 % Nail Lacquer Sol Packsize 3 Alprostadil 250 Micrograms Sls Urethral Stick Packsize 6 Amorolfine 5 % Nail Lacquer Sol Packsize 5 Alprostadil 250 Micrograms
Load more

Recommended publications
  • Core Topics in Mechanical Ventilation Edited by Iain Mackenzie Index More Information
    Cambridge University Press 978-0-521-86781-8 - Core Topics in Mechanical Ventilation Edited by Iain Mackenzie Index More information Index Abdominal distension in lung elastance oxygen toxicity 270 incidence data 240 345, 346 patient assessment 118, 115–119, 120 laryngeal injuries 248, 247–248 Abdominal paradox 27 recruitment manoeuvres 118–119, left ventricular performance 273 N-Acetylcysteine 79–80, 81, 357, 358 131, 219 lorazepam 165 Acinetobacter baumanii, SDD for 260 trials (See ARDS net trials) lung injury, ventilator-associated (See Acute hypoxaemic respiratory failure ventilation management Lung injury, defined 115 HFOV 127–131, 305–306 ventilator-associated) Acute lung injury (ALI) IRV 125–126 maxillary sinusitis/middle ear blast injuries 212 liquid 228 effusions 246–247 hypoxaemia, PEEP management of modes 215–216 midazolam 165 124–125 overview 214 nasopharyngeal airways 243–245, infants/children 300–301 principles 214–215, 216 246–247 liquid ventilation 228 Acute respiratory failure (ARF) nasotracheal intubation 315 patient assessment 118, 115–119, clinical presentation 29 neurological function 277, 276–277, 120, 197 mechanisms of 24 278, 280 recruitment manoeuvres 131, 219 NIV 43, 49–50 (See also Non-invasive NMBAs 171, 176–177, 276–280 ventilation management ventilation (NIV)) NSAIDs 181 HFV 149–150 overview 24, 22–24, 25, 142 opioid agonists 180 IRV 125–126 Adaptive support ventilation® 113, 361 opioids 276–280 modes 215–216 Adrenaline 81 overview 21, 239, 241 overview 214 Adrenergic receptor antagonists 349, oxygen toxicity
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew Et Al
    US009314465B2 (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew et al. (45) Date of Patent: *Apr. 19, 2016 (54) DRUG COMBINATIONS AND USES IN 2008.0003280 A1 1/2008 Levine et al. ................. 424/456 TREATING A COUGHING CONDITION 2008/O176955 A1 7/2008 Hecket al. 2008, 0220078 A1 9, 2008 Morton et al. (71) Applicant: Infirst Healthcare Limited 2009, O136427 A1 5/2009 Croft et al. 2009, O220594 A1 9, 2009 Field (72) Inventors: John Brew, London (GB); Robin Mark 2012/O128738 A1 5, 2012 Brew et al. Bannister, London (GB) 2012fO252824 A1 10/2012 Brew et al. (73) Assignee: Infirst Healthcare Limited, London FOREIGN PATENT DOCUMENTS (GB) CN 1593451 3, 2005 CN 101024.014 A 8, 2007 (*) Notice: Subject to any disclaimer, the term of this CN 101112383 B 5, 2010 patent is extended or adjusted under 35 DE 4420708 A1 12, 1995 U.S.C. 154(b) by 0 days. EP 2050435 B1 4/2009 GB 2114001 A 8, 1983 This patent is Subject to a terminal dis GB 2284761 A 6, 1995 claimer. GB 2424.185 B 9, 2006 GB 2442828 A 4/2008 JP 62-249924 A 10, 1987 (21) Appl. No.: 14/287,014 JP H1O-316568 A 12/1998 JP 2001-518928 A 10, 2001 (22) Filed: May 24, 2014 JP 200219.3839. A T 2002 JP 2003-012514 A 1, 2003 (65) Prior Publication Data JP 20030552.58 A 2, 2003 JP 2003128549 A 5, 2003 US 2014/O256750 A1 Sep. 11, 2014 JP 2003-321357 A 11, 2003 JP 2005-516917 A 6, 2005 JP 2008O31146 A 2, 2008 Related U.S.
    [Show full text]
  • NEW Products
    NEW Products NEW Products - January 2021 NEW Generics PIP CODE PRODUCT PACK 1236082 Dexamethasone Tablets 500mcg 28 7747462 Diltiazem Tablets 60mg 84 5018957 Mebeverine 50mg/5ml Oral Suspension 300ml NEW UK Feeds PIP CODE PRODUCT PACK 3655545 Fresubin 2kcal Fibre Apricot/Peach 4x200m 3 NEW Products 3442803 Fresubin 2kcal Fibre Cappucino 4x200m 3438264 Fresubin 2kcal Fibre Chocolate 4x200m 3442795 Fresubin 2kcal Fibre Lemon 4x200m 5 Generics 3655537 Fresubin 2kcal Fibre Neutral 4x200m www.de-group.co.uk 3442944 Fresubin 2kcal Fibre Vanilla Pack 4x200m 4022950 Fresubin 2kcal Mini Apricot/Peach 4x125m 44 Parallel Imports 4022976 Fresubin 2kcal Mini Fibre Chocolate 4x125m 4022984 Fresubin 2kcal Mini Fibre Vanilla 4x125m 4022968 Fresubin 2kcal Mini FOTF 4x125m 3 60 UK Ethicals 4022943 Fresubin 2kcal Mini Vanilla 4x125m 3771334 Polycal Liquid Bottle Neutral 200ml 3771326 Polycal Liquid Bottle Orange 200ml 70 UK Feeds NEW UK Dressings PIP CODE PRODUCT PACK 74 Parallel Import Feeds 3272887 Airzone Peak Flow Meter 15 3793965 Biatain Adhesive 7.5x7.5 10 3798469 Clinifilm Wipes 30 76 Dressings 3902756 Clinimed LBF Foam Applicator 2ml 5 2896439 Clinimed LBF NonSting Bar Film Wipes 30 90 3694924 Cutimed Protect Cream 90g OTC 3694916 Cutimed Protect Cream 28g 3694890 Cutimed Protect Foam 1ml 5 3694908 Cutimed Protect Foam 3ml 5 134 Dispensing 3694882 Cutimed Protect Spray 28ml 3722238 Cutimed Sorbion Sachet Extra 20x10 5 3883402 Cutimed Sorbion Sachet XL 45cmx25cm 5 136 Vets 3942018 Devon Foot And Heel Protector 2 227074 Kaltostat Rope Cavity Wound
    [Show full text]
  • Automation List – 1St December 2011
    st Automation List – 1 December 2011 Abidec Drops Packsize 25 Adcal D3 Chewable Tabs Packsize 56 Abilify Tabs 10 Mg Packsize 28 Adcal D3 Chewable Tabs Packsize 56 Abstral Tabs 100 Micrograms Packsize 10 Adcal D3 Dissolve Effervescent Tabs Packsize 56 Abstral Tabs 100 Micrograms Packsize 30 Adcal D3 Tabs Packsize 112 Abstral Tabs 200 Micrograms Packsize 10 Adefovir Dipivoxil Tabs 10 Mg Packsize 30 Abstral Tabs 200 Micrograms Packsize 30 Adenuric Tabs 80 Mg Packsize 28 Abstral Tabs 300 Micrograms Packsize 10 Adipine 10 Mr 10 Mg Tabs Packsize 56 Abstral Tabs 300 Micrograms Packsize 30 Adipine 20 Mr 20 Mg Tabs Packsize 56 Abstral Tabs 400 Micrograms Packsize 10 Adipine 30 Xl Tabs 30 Mg Packsize 28 Abstral Tabs 400 Micrograms Packsize 30 Adipine 60 Xl Tabs 60 Mg Packsize 28 Abstral Tabs 600 Micrograms Packsize 30 Adizem Sr 120 Mg Caps Packsize 56 Acamprosate Calcium 333 Mg Ec Tabs Packsize 168 Adizem Sr 180 Mg Caps Packsize 56 Acarbose Tabs 100 Mg Packsize 90 Adizem Sr 90 Mg Caps Packsize 56 Acarbose Tabs 50 Mg Packsize 90 Adizem Sr Tabs 120 Mg Packsize 56 Accolate Tabs 20 Mg Packsize 56 Adizem Xl 120 Mg Caps Packsize 28 Accupro Tabs 10 Mg Packsize 28 Adizem Xl 180 Mg Caps Packsize 28 Accupro Tabs 20 Mg Packsize 28 Adizem Xl 200 Mg Caps Packsize 28 Accupro Tabs 40 Mg Packsize 28 Adizem Xl 240 Mg Caps Packsize 28 Accupro Tabs 5 Mg Packsize 28 Adizem Xl 300 Mg Caps Packsize 28 Accuretic Tabs Packsize 28 Adoport Caps 1 Mg Packsize 100 Acebutolol Caps 100 Mg Packsize 84 Adoport Caps 1 Mg Packsize 50 Acebutolol Caps 200 Mg Packsize 56 Adoport Caps
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • Laws of Trinidad and Tobago Ministry of Legal Affairs
    LAWS OF TRINIDAD AND TOBAGO MINISTRY OF LEGAL AFFAIRS www.legalaffairs.gov.tt FOOD AND DRUGS ACT CHAPTER 30:01 Act 8 of 1960 Amended by 39 of 1968 156/1972 *31 of 1980 16 of 1986 12 of 1987 6 of 1993 16 of 1998 6 of 2005 *See Note on Validation at page 2 Current Authorised Pages Pages Authorised (inclusive) by L.R.O. 1–2 .. 3–20 .. 21–245 .. UNOFFICIAL VERSION L.R.O. UPDATED TO DECEMBER 31ST 2014 LAWS OF TRINIDAD AND TOBAGO MINISTRY OF LEGAL AFFAIRS www.legalaffairs.gov.tt 2 Chap. 30:01 Food and Drugs Index of Subsidiary Legislation Page Food and Drugs Regulations (GN 130/1964) … … … … 25 Official Method Notification (GN 54/1972) … … … … 124 *Approval of New Drugs Notification … … … … … 129 †Withdrawal of Approval of New Drugs Notification (GN 51/1969) … … 200 Fish and Fishery Products Regulations (LN 220/1998)…………201 †This Notification (i.e. 51/1969) has been amended by LNs 99 and 114/1984 which have been omitted. *Note on Approval of New Drugs Notification The list of new drugs set out in the Schedule to this Notification has been consolidated as at 31st December 1977. This list is so voluminous and changes to it so frequent that, especially in view of its very limited use by the general public, it is not practicable to update it annually. The references to the amendments to this list since 31st December 1977 are contained in the Current Consolidated Index of Acts and Subsidiary Legislation. †Note on Withdrawal of Approval of New Drugs Notification For references to the Withdrawal of Approval of New Drugs Notifications subsequent to the year 1969 — See the current Consolidated Index of Acts and Subsidiary Legislation.
    [Show full text]
  • United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug
    USOO544607OA United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug. 29, 1995 54 COMPOST ONS AND METHODS FOR 4,659,714 4/1987 Watt-Smith ......................... 514/260 TOPCAL ADMNSTRATION OF 4,675,009 6/1987 Hymes .......... ... 604/304 PHARMACEUTICALLY ACTIVE AGENTS 4,695,465 9/1987 Kigasawa .............................. 424/19 4,748,022 5/1988 Busciglio. ... 424/195 75 Inventor: Juan A. Mantelle, Miami, Fla. 4,765,983 8/1988 Takayanagi. ... 424/434 4,789,667 12/1988 Makino ............ ... 514/16 73) Assignee: Nover Pharmaceuticals, Inc., Miami, 4,867,970 9/1989 Newsham et al. ... 424/435 Fla. 4,888,354 12/1989 Chang .............. ... 514/424 4,894,232 1/1990 Reul ............. ... 424/439 * Notice: The portion of the term of this patent 4,900,552 2/1990 Sanvordeker .... ... 424/422 subsequent to Aug. 10, 2010 has been 4,900,554 2/1990 Yanagibashi. ... 424/448 disclaimed. 4,937,078 6/1990 Mezei........... ... 424/450 Appl. No.: 112,330 4,940,587 7/1990 Jenkins ..... ... 424/480 21 4,981,875 l/1991 Leusner ... ... 514/774 22 Filed: Aug. 27, 1993 5,023,082 6/1991 Friedman . ... 424/426 5,234,957 8/1993 Mantelle ........................... 514/772.6 Related U.S. Application Data FOREIGN PATENT DOCUMENTS 63 Continuation-in-part of PCT/US92/01730, Feb. 27, 0002425 6/1979 European Pat. Off. 1992, which is a continuation-in-part of Ser. No. 0139127 5/1985 European Pat. Off. 813,196, Dec. 23, 1991, Pat. No. 5,234,957, which is a 0159168 10/1985 European Pat.
    [Show full text]
  • Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine 2013
    Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine, Pyrimidine, Azaindole, Quinoline, Thiazole, Isatin, Phenanthrene, Thiophene We declare that some of the listed products might be protected by valid patents. They are only for scientific research and development purpose. They are not offered for sales in countries where the sales of such products constitutes patents infringement. The liability for patents checking and patents infringement is exclusive at buyers risk! I2CNS LLC CANNOT BE HELD LIABLE FOR ANY VIOLATIONS OF PATENT RIGHTS CAUSED BY CUSTOMERS. CAS No. Product Name and Description 26988-72-7 1-METHYL-DL-TRYPTOPHAN 68886-07-7 2-Fluoro-4-hydroxyphenylaceticacid 72607-53-5 N-(3-AMINOPROPYL)METHACRYLAMIDE 171049-41-5 7-AMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLICACIDTERT- BUTYLESTER 885280-38-6 (3-OXO-CYCLOHEXYL)-CARBAMICACIDTERT-BUTYLESTER 186826-86-8 MOXIFLOXACIN HCL 102735-53-5 L-CYCLOPROPYLALANINE 145100-50-1 2-[N,N-BIS(TRIFLUOROMETHYLSULFONYL)AMINO]PYRIDINE 143491-57-0 Emtricitabine 39809-25-1 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one 147127-20-6 Tenofovir 716-39-2 2,3-NAPHTHALENEDICARBOXYLICANHYDRIDE 4333-62-4 1,3-DIMETHYLIMIDAZOLIUMIODIDE 108-45-2 m-Phenylenediamine 1961-72-4 R-(3)-HYDROXYMYRISTICACID 131-48-6 N-Acetylneuraminicacid 88196-70-7 (R)-1-(3-Methoxyphenyl)ethylamine 680-31-9 Hexamethylphosphoramide 486-66-8 Daidzein 872-50-4 1-Methyl-2-pyrrolidinone 425378-68-3 2-FLUORO-5-NITROPHENYLBORONICACIDPINACOLESTER 115651-29-1 5-ACETYL-2-AMINO-4-HYDROXYBENZOICACID 115269-99-3 N,N-BIS-BOC-N-ALLYLAMINE
    [Show full text]
  • Pharmaceutical Compoundingand Dispensing, Second
    Pharmaceutical Compounding and Dispensing Pharmaceutical Compounding and Dispensing SECOND EDITION John F Marriott BSc, PhD, MRPharmS, FHEA Professor of Clinical Pharmacy Aston University School of Pharmacy, UK Keith A Wilson BSc, PhD, FRPharmS Head of School Aston University School of Pharmacy, UK Christopher A Langley BSc, PhD, MRPharmS, MRSC, FHEA Senior Lecturer in Pharmacy Practice Aston University School of Pharmacy, UK Dawn Belcher BPharm, MRPharmS, FHEA Teaching Fellow, Pharmacy Practice Aston University School of Pharmacy, UK Published by the Pharmaceutical Press 1 Lambeth High Street, London SE1 7JN, UK 1559 St Paul Avenue, Gurnee, IL 60031, USA Ó Pharmaceutical Press 2010 is a trade mark of Pharmaceutical Press Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society of Great Britain First edition published 2006 Second edition published 2010 Typeset by Thomson Digital, Noida, India Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 912 5 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of John F Marriott, Keith A Wilson, Christopher A Langley and Dawn Belcher to be identified as the author of this work has been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Cambridgeshire Joint Prescribing Group 2004
    Date Printed 13/12/201722/11/201721/11/201728/09/2017 Current Commissioning Indication Last date Relevant Approved name Classification and Responsibility Rationale for Next Review Covered by this classified by NICE (Brand Name) Priority Funding Decision Due Classification CPJPG Guidance Position NHSE CCG CAMBRIDGESHIRE & PETERBOROUGH CCG FORMULARY Classification of Prescribing Responsibility Skip to Alphabetical Index Foreword This document is an appendix to the Cambridgeshire and Peterborough CCG Formulary Medicines considered by the CPJPG are included in this document. In general, only medicines classified as ‘NOT RECOMMENDED’ and ‘HOSPITAL ONLY’ are retained in this document long-term whilst all others are removed after 6 months as they are included in the CCG Formulary. Definitions of the recommendations made by the Cambridgeshire and Peterborough Joint Prescribing Group (CPJPG) can be found in the explanatory notes Any medication/drug licensed or becoming available after the revision date (below) for this document and not considered by CPJPG should be regarded as ‘Not Recommended’ or ‘Hospital only’. Omission of a drug from this table cannot be taken to indicate that it is recommended for prescribing in either primary or secondary care. (i.e. any medicine not listed in either the classification table or the formulary are classified as “Not recommended” ) Please contact the Medicines Management Team for further advice. Cambridgeshire and Peterborough CCG have undertaken a prioritisation process and agreed that some therapies will not be a priority for funding and will therefore not be funded other than in exceptional circumstances. This appendix to the formulary is a continually evolving document and will be updated after each CPJPG meeting (every 2 months).
    [Show full text]